根据最近的SEC文件显示，Hims & Hers Health, Inc. (NYSE:HIMS)的董事Manuel Anja近期购买了该公司5,000股A类普通股。Anja于11月12日以每股$26.9399的价格购入4,000股，并于11月14日以每股$24.50的价格购入额外1,000股。这些交易总计价值$132,259。此次购买使Anja的直接所有权增加到公司5,000股。

周四，美银证券将Hims & Hers Health, Inc. (NYSE: HIMS)的评级从买入下调至表现不佳。这一决定是对亚马逊最近进入勃起功能障碍（ED）和脱发市场的直接回应，这两个领域是Hims & Hers的主要业务板块。

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy.

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment ...

Walt Disney’s earnings beat Wall Street estimates, Super Micro Computer extends losses, and Cisco posts fiscal first-quarter ...

Hims & Hers once again delivered a blowout quarter with surging revenue. Revenue soared 77% year over year to $401.6 million, ...

Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...

In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...